COVID-19 and Substance Use: A Scientometric Assessment of Global Publications During 2020 and 2021

ABSTRACT

Aim: This study aimed to assess the characteristics and trends of research on substance use and COVID-19. Methods: Keywords related to “Covid-19” and “Substance Use” were used in a search query formulated for the Scopus search engine. The articles published during the years 2020 and 2021, through early November 2021, were considered. Results: A total of 2184 publications were published on this topic, averaging 9.69 citations per paper. About one-seventh (13.96%) share of global publications was supported by extramural funding support. The maximum number of publications emerged from the United States of America (USA) (n = 831; 38.05%), followed by the United Kingdom (UK) (n = 212; 9.71%), India (n = 165; 7.55%), and Canada (155 papers; 7.10%). In terms of citation impact, publications emerging from China (24.42 and 2.52) had the highest citation impact, followed by publications emerging from Australia (18.83 and 1.94), France (16.48 and 1.70), the UK (15.44 and 1.59), Italy (13.36 and 1.38), and Canada (12.73 and 1.31). When the data in terms of specific institutes were evaluated, Harvard Medical School, USA (n = 52), was ranked first in productivity, followed by the University of Toronto, Canada (n = 47); the Yale School of Medicine, USA (n = 35); INSERM, France (n = −29); and the University of British Columbia, Canada (n = 2s). The University College London, UK (30.24 and 3.12), ranked first in citation impact, followed by INSERM, France (22.0 and 2.27); the Sapienza University of Rome, Italy (17.4 and 1.8); and the University of Toronto, Canada (13.68 and 1.41). When the journals were evaluated, the International Journal of Environmental Research and Public Health (n = 83) ranked first in publication productivity, followed by the Journal of Substance Abuse Treatment (n = 73), Frontiers in Psychology (n = 39), Drug and Alcohol Dependence (n = 28), and International Journal of Drug Policy (n = 26). Conclusion: This bibliometric study suggests that a large amount of literature has accumulated during the COVID-19 pandemic on substance use disorders, both from developed and developing countries.

KEYWORDS

• COVID-19
• Substance use
• Global publications
• Scientometrics
• Bibliometric

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.1177/0976500X221080393Copy

RELATED ARTICLES

Matched on section and article type within this issue of J Pharmacol. Pharmacother..

• Article · VOLUME 13, ISSUE 1Systematic Review and Meta-Analysis Comparing the Safety of Natalizumab, Ocrelizumab, and Alemtuzumab in Treating Relapsing–Remitting, Primary Progressive, and Secondary Progressive Multiple SclerosisPooja Raina, Somnath Basu, Ramesh K Goyal, Pravat K Sahoo, Rajani Mathur · pp. 14–23Research ArticleSame type: Article
• Article · VOLUME 13, ISSUE 1Review of the Long-Term Effect of the Atypical Antipsychotic Medication on the Bone Mineral Density of the Pediatric Patient with Consideration of Autism Spectrum DisorderWisam Al Jumaili, Ashraf Muzwagi · pp. 24–30Research ArticleSame type: Article
• Article · VOLUME 13, ISSUE 1The Role of Olfactory System in the Etiogenesis of Parkinson’s Diseases: An OverviewJiju Narayanan Avanipully, Dithu Thekkekkara, Sahyadri M, Vipan K. Parihar, Santhepete Nanjundaiah Manjula · pp. 31–39Research ArticleSame type: Article
• Article · VOLUME 13, ISSUE 1Ethnopharmacology Research: A Scientometric Assessment of Indian Publications During 2011 to 2020Chaman Sab M., Mallikarjun Kappi, K.K. Mueen Ahmed · pp. 48–58Research ArticleSame type: Article